Global Amdinocillin Market Is Expected To Grow At A CAGR Of 3.0% From 2020 To 2027

Amdinocillin has broad-spectrum activity against infections caused due to gram-negative bacteria. The oral bioavailability of amdinocillin is very low hence its prodrug pivmecillinam is prescribed for treatment of urinary tract infection, typhoid, pyelonephritis, etc. Urinary tract infections are leading the treatment segment for the amdinocillin market. It is usually caused by gram-negative bacteria such as […]